Katia Pagnano

15PUBLICATIONS
82CO-AUTHORS
Molecular targetsHaematologyFoetal development and medicineMedical genetics (excl. cancer genetics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 30, 2026
The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Maria Agustina Perusini, Katia Pagnano, Carolina Pavlovsky

|Jun 13, 2025
Circulating Monocytes Contribute to Erythrocyte Clearance in Polycythemia Vera.

Marina D Borges, Izabela F Paes, Daniela P Leonardo

|Mar 07, 2025
Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case report.

Géssika B G M Gutierrez de Moraes Pereira, Victor A Rocha, Paulo Victor R Barbosa

|Oct 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry.

Valeria Buccheri, Frederico Rafael Moreira, Irene Biasoli

|Jul 05, 2024
Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States.

Ana Carolina Mourão Toreli, Marisol Miranda-Galvis, Muhannad Sharara

|May 28, 2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.

Luísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga

Pageof 3

Frequent Collaborators

4 joint publications

Eduardo M Rego

4 joint publications

Raul Ribeiro

3 joint publications

Miguel Sanz

3 joint publications

Douglas R Silveira